anti-platelet/ anti-coagulant Flashcards
warfarin mechanism of action
- vitamin K antagonist
- inhibits vitamin K reductase and therefore stops the activation of vitamin K dependent zymogens
- needs bridge therapy because it only stops new vitamin K dependent zymogens from forming so there is the current storage
warfarin antidote
- plasma
- vitamin K
- PCC prothrombin complex concentrate (factor II)
why does warfarin need a bridge therapy drug?
- needs bridge therapy because it only stops new vitamin K dependent zymogens from forming so there is the current storage
warfarin is contraindicated in
pregnant women
warfarin side effects
bleeding
How do you monitor warfarin?
weekly INR/PT and then monthly
What is warfarin used to treat?
- prevention of stroke in a fib patients
- prevention of thrombosis in mechanical hearts and valves
- VTE
heparin’s mechanism of action
binds antithrombin to inactivate factor X and thrombin
un-fractionalized heparin must be administered
in the hospital
heparins antidote
sulfate protamine
low molecular weight heparin
enoxaparin and lovenox
how do you monitor heparin
aPTT and anti-Xa levels
how do you monitor enoxaparin (lovenox)?
anti-Xa levels
mechanism of action for enoxaparin (lovenox)?
deactivates Xa via binding to
what anti-coagulations are degraded by the kidney?
enoxaparin (lovenox) and fondaparinux
argatroban is hepatically/renally metabolized?
hepatically
low molecular weight heparin is used for
pregnant women and patients with cancer
can oral anticoagulants be used for patients who have mechanical hearts or valves?
NO
what is a pro of oral anticoagulants?
decreased intracranial bleeds
what is the antidote for low molecular weight heparin?
there is no antidote
which anticoagulants require antithrombin binding for activation?
heparin and low molecular weight heparin like enoxaparin (lovenox) and fondaparinux
argatroban binds directly to
thrombin
dabigatran mechanism of action
orally; binds prothrombin
how is argatroban administered
IV
what is the antidote to dabigatran?
idarucisumab
idarucisumab
fab fragment that binds and inactivates dapigatran
rivaroxaban, apixaban, and edoxaban
are all Xa inactivators